These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [111In-pentetreotide in the study of tumors expressing somatostatin receptors]. Mateos Fernández J; Pons Pons F; Fuster Pelfort D; Vidal-Sicart S; Lomeña Caballero F; Herranz García-Romero R Rev Esp Med Nucl; 1999 Oct; 18(5):325-30. PubMed ID: 10562660 [TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma]. Hoefer M; Schmidt S; Welter J; Kirsch CM; Ukena D; Sybrecht GW Pneumologie; 1998 Feb; 52(2):106-12. PubMed ID: 9557059 [TBL] [Abstract][Full Text] [Related]
12. Indium-111-pentetreotide imaging in intra-axial brain tumors: comparison with thallium-201 SPECT and MRI. Lee JD; Kim DI; Lee JT; Chang JW; Park CY J Nucl Med; 1995 Apr; 36(4):537-41. PubMed ID: 7699438 [TBL] [Abstract][Full Text] [Related]
13. [Indium-111-DTPA-phenyl-pentetreotide somatostatin receptors' scintigraphy in the evaluation of patients with suspected gastro-entero-pancreatic tumors. Comparison with computerized tomography]. Gerasimou GP; Aggelopoulou T; Papanastasiou E; Konidari-Dedousi E; Prousalidis I; Psarrakos K; Siountas A; Molybda E; Gotzamani-Psarrakou A Hell J Nucl Med; 2007; 10(3):209-14. PubMed ID: 18084669 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors. Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177 [TBL] [Abstract][Full Text] [Related]
15. Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy. Lebtahi R; Le Cloirec J; Houzard C; Daou D; Sobhani I; Sassolas G; Mignon M; Bourguet P; Le Guludec D J Nucl Med; 2002 Jul; 43(7):889-95. PubMed ID: 12097458 [TBL] [Abstract][Full Text] [Related]
16. [Imaging of somatostatin receptor using 111In-pentetreotide]. Kimura T; Sakahara H; Higashi T; Honda T; Konishi J; Hosotani R; Oshio G; Imamura M; Inokuma T Kaku Igaku; 1996 Apr; 33(4):447-52. PubMed ID: 8683886 [TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor scintigraphy of malignant somatostatinoma with indium-111-pentetreotide. Schillaci O; Annibale B; Scopinaro F; delle Fave G; Colella AC J Nucl Med; 1997 Jun; 38(6):886-7. PubMed ID: 9189135 [TBL] [Abstract][Full Text] [Related]
18. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129 [TBL] [Abstract][Full Text] [Related]